[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.92.239.248. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 325
Citations 0
Comment & Response
September 9, 2013

Patient Preferences for Deactivation of Implantable Cardioverter-Defibrillators

Author Affiliations
  • 1Department of Cardiology, Heart of England NHS Foundation Trust, Birmingham, England
  • 2Centre for the Study of Choice, University of Technology, Sydney, New South Wales, Australia
  • 3Faculty of Nursing, University of Alberta, Edmonton Alberta, Canada
JAMA Intern Med. 2013;173(16):1556-1557. doi:10.1001/jamainternmed.2013.8141

To the Editor The Research Letter on patient preferences for deactivation of implantable cardioverter-defibrillators (ICDs) provides useful data that may help avoid some device-related dilemmas increasingly encountered in clinical practice.1 Patients often intuitively accept the evidence-based offer of ICD therapy to avoid the specter of sudden death without fully appreciating the consequences of that decision.

First Page Preview View Large
First page PDF preview
First page PDF preview
×